155 related articles for article (PubMed ID: 37053536)
1. Pediatric Rectal Adenocarcinoma With Mismatch Repair Deficiency Responds to Immunotherapy.
Qureshi N; Hoffman TL; Kaneva K; Zomorrodian S; Scapa JV; Hitchins MP; Federman N
JCO Precis Oncol; 2023 Apr; 7():e2200378. PubMed ID: 37053536
[No Abstract] [Full Text] [Related]
2. Heterogeneity of mismatch repair defect in colorectal cancer and its implications in clinical practice.
Tachon G; Frouin E; Karayan-Tapon L; Auriault ML; Godet J; Moulin V; Wang Q; Tougeron D
Eur J Cancer; 2018 May; 95():112-116. PubMed ID: 29519639
[No Abstract] [Full Text] [Related]
3. Colorectal cancer under 20 years old: a retrospective analysis from three tertiary hospitals.
Zhou C; Xiao W; Wang X; Chen H; Niu S; Wang Q; Chang H; Wu X; Ding P; Pan Z; Wan X; Bao Y; Gao Y
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1145-1155. PubMed ID: 32968876
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas.
Papke DJ; Yurgelun MB; Noffsinger AE; Turner KO; Genta RM; Redston M
N Engl J Med; 2022 Nov; 387(18):1714-1716. PubMed ID: 36322852
[No Abstract] [Full Text] [Related]
5. Tumor Grade Is Prognostically Relevant Among Mismatch Repair Deficient Colorectal Carcinomas.
Johncilla M; Chen Z; Sweeney J; Yantiss RK
Am J Surg Pathol; 2018 Dec; 42(12):1686-1692. PubMed ID: 30179899
[TBL] [Abstract][Full Text] [Related]
6. Colorectal Tumors From Different Racial and Ethnic Minorities Have Similar Rates of Mismatch Repair Deficiency.
Berera S; Koru-Sengul T; Miao F; Carrasquillo O; Nadji M; Zhang Y; Hosein PJ; McCauley JL; Abreu MT; Sussman DA
Clin Gastroenterol Hepatol; 2016 Aug; 14(8):1163-71. PubMed ID: 27046481
[TBL] [Abstract][Full Text] [Related]
7. [Pathological complete response of a metastatic MisMatch Repair deficient/MicroSatellite Instable colon cancer after immunotherapy: A case report].
Brochard C; Chicaud M; Colle R; Parc Y; Svrcek M
Ann Pathol; 2022 Mar; 42(2):172-176. PubMed ID: 34991922
[TBL] [Abstract][Full Text] [Related]
8. Primary adenocarcinoma of the bladder lacks mismatch repair deficiency and demonstrates PD-L1 expression in tumor-infiltrating immune cells, with implications in both diagnosis and therapeutics.
Jones D; Guan JJ; Calagua C; Hansel DE; Epstein JI; Ye H
Hum Pathol; 2019 Dec; 94():58-63. PubMed ID: 31666198
[TBL] [Abstract][Full Text] [Related]
9. Molecular Evaluation of Colorectal Adenocarcinoma: Current Practice and Emerging Concepts.
Nowak JA; Hornick JL
Surg Pathol Clin; 2016 Sep; 9(3):427-39. PubMed ID: 27523970
[TBL] [Abstract][Full Text] [Related]
10. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
[TBL] [Abstract][Full Text] [Related]
11. Deficient DNA mismatch repair is associated with favorable prognosis in Thai patients with sporadic colorectal cancer.
Korphaisarn K; Pongpaibul A; Limwongse C; Roothumnong E; Klaisuban W; Nimmannit A; Jinawath A; Akewanlop C
World J Gastroenterol; 2015 Jan; 21(3):926-34. PubMed ID: 25624727
[TBL] [Abstract][Full Text] [Related]
12. Precancerous lesions of the colorectum.
Fujimori T; Kawamata H; Kashida H
J Gastroenterol; 2001 Sep; 36(9):587-94. PubMed ID: 11578061
[No Abstract] [Full Text] [Related]
13. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
González I; Goyal B; Xia MD; Pai RK; Ma C
Hum Pathol; 2019 Mar; 85():18-26. PubMed ID: 30381262
[TBL] [Abstract][Full Text] [Related]
14. American Gastroenterological Association Institute and College of American Pathologists Quality Measure Development for Detection of Mismatch Repair Deficiency and Lynch Syndrome Management.
Leiman DA; Cardona DM; Kupfer SS; Rosenberg J; Bocsi GT; Hampel H;
Gastroenterology; 2022 Feb; 162(2):360-365. PubMed ID: 34666049
[No Abstract] [Full Text] [Related]
15. Mismatch repair deficiency is implicated in carcinoma arising from ovarian teratoma.
Cheung AH; Chow C; Yu MY; Law WW; Law PP; Choi PC; Kang W; To KF
Pathology; 2019 Jan; 51(1):67-73. PubMed ID: 30502217
[TBL] [Abstract][Full Text] [Related]
16. Validation of a targeted next-generation sequencing approach to detect mismatch repair deficiency in colorectal adenocarcinoma.
Papke DJ; Nowak JA; Yurgelun MB; Frieden A; Srivastava A; Lindeman NI; Sholl LM; MacConaill LE; Dong F
Mod Pathol; 2018 Dec; 31(12):1882-1890. PubMed ID: 29955144
[TBL] [Abstract][Full Text] [Related]
17. Colorectal adenocarcinoma: a pediatric case review with a focus on mismatch repair gene mutations and E-cadherin expression.
Gonzalez RS; Shulman SC; Katzenstein HM; Steelman CK; Wulkan ML; Abramowsky CR; Cohen C; Davis GK; Shehata BM
Pediatr Dev Pathol; 2012; 15(3):192-8. PubMed ID: 21985494
[TBL] [Abstract][Full Text] [Related]
18. Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults.
Shaikh T; Handorf EA; Meyer JE; Hall MJ; Esnaola NF
JAMA Oncol; 2018 Feb; 4(2):e173580. PubMed ID: 29121143
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features.
Chang DT; Pai RK; Rybicki LA; Dimaio MA; Limaye M; Jayachandran P; Koong AC; Kunz PA; Fisher GA; Ford JM; Welton M; Shelton A; Ma L; Arber DA; Pai RK
Mod Pathol; 2012 Aug; 25(8):1128-39. PubMed ID: 22481281
[TBL] [Abstract][Full Text] [Related]
20. Effective Immunotherapy of Glioblastoma in an Adolescent with Constitutional Mismatch Repair-Deficiency Syndrome.
Pavelka Z; Zitterbart K; Nosková H; Bajčiová V; Slabý O; Štěrba J
Klin Onkol; 2019; 32(1):70-74. PubMed ID: 30764633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
